AI-Powered Pathology (Paige AI)

AI-Powered Pathology, led by Paige AI's FDA-cleared prostate cancer detection system, was deployed in over 50 major cancer centers by 2025, analyzing whole-slide pathology images to identify cancerous cells with 97.8% sensitivity—significantly surpassing human pathologists alone, whose average sensitivity is 85%. Its Paige Prostate and Paige Breast tools processed 1 million pathology slides in 2024, with studies showing AI assistance reduced false positive rates by 30% and false negative rates by 40% for oncologists. This system is 15% more accurate than the average human pathologist in detecting early-stage cancers, setting a new benchmark for diagnostic precision.